Tecelra Injection, Suspension
Product Images NDC 87262-160

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tecelra (NDC 87262-160). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Uswm Ct, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Principal Display Panel (Bag and Cassette Label)

Principal Display Panel (Bag and Cassette Label)
This is a description of a product called afamitresgene autoleucel (Tecelra®) intended for autologous and intravenous use only. The product contains MAGE-A4 TCR positive T cells in a frozen suspension with 5% DMSO. It is important to gently mix the suspension for intravenous infusion after thawing. The manufacturer is USWM CT, LLC based in Philadelphia, PA, USA. For full prescribing information and administration instructions, refer to the product packaging. Storage and transport should be done at temperatures below -130°C. The product has not been evaluated for infectious substances. It is recommended not to use a leukodepleting filter or irradiate the product while administering. For more information, contact the manufacturer at 1-855-246-9232.*
FDA Label Image

Teclelra-bag Patient Info (Tecelra Bag)

Teclelra-bag Patient Info (Tecelra Bag)
FDA Label Image

Tecelra-cassette Patient Info (Tecelra Cass)

Tecelra-cassette Patient Info (Tecelra Cass)
This document appears to be a patient profile for the administration of afamitresgene autoleucel, also known as Tecelra®s. It includes fields for patient information such as name, date of birth, DIN (Drug Identification Number), and other identifiers. There is a note indicating the need to confirm patient identifiers before infusion. The expiration date of the medication is also listed as December 31, 2024.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.